Dominic Borie
Vermögen: 803 880 $ am 31.08.2026
Vermögen: 803 880 $ am 31.08.2026
Dr. Dominic Borie is a Chief Medical Officer, Head-Research & Development at Cue Biopharma, Inc. Dr. Borie was previously employed as a President-Research & Development by Kyverna Therapeutics, Inc., a VP, Head-External Research & Development by Horizon Therapeutics Ltd. (Ireland), a Senior Medical Director by Genentech, Inc., a Medical Director by Amgen, Inc., a Director-Transplantation Research by Roche Pharmaceuticals, Inc., a Director-Transplantation Immunology Laboratory by Stanford University, and an Executive Director by Allogene Therapeutics, Inc. He received his undergraduate degree from North Carolina State University, a doctorate degree from Universite Paris Est Creteil Val De Marne, a doctorate degree from Universite Paris Cite and a doctorate degree from The University of Texas at Austin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,43 % | 13.07.2026 | 31.500 ( 0,43 % ) | 803 880 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CUE BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.07.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Vorstandsvorsitzender | 13.10.2022 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.01.2020 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2016 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01.12.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universite Paris Est Creteil Val De Marne
Universite Paris Est Creteil Val De Marne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen